FDA helps out with diagnostic assay guidance
This article was originally published in Clinica
Executive Summary
In response to numerous requests for help from industry, the US FDA has developed a draft guidance on how to prepare a product submission for diagnostic assays that yield multiple simultaneous results. The new guidance document was developed after 24 months of participation at a number of seminars and workshops discussing the criteria that are important in the analytical and clinical validation of multiplex assays.